SANGUI BIOTECH INTERNATIONAL INC
company.status.inactiveCIK 1104280fmd_14DGXJ5RHRMBVGGAWBFF1E06ADManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Mar 31, 2023, 51 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Realized investment gains (losses) | – | – | – | – | – | – | – | – | – | – |
| Research and development | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | (1) | (1) | (1) | (0) | (0) | (0) | (0) | (0) | (0) | (0) |
| Interest expense | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Other non-operating income (expense) | – | (0) | (0) | – | – | (0) | (0) | (0) | (0) | 0 |
| Income before taxes | (2) | (2) | (1) | (0) | (0) | (0) | – | – | – | – |
| Income tax expense | – | – | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (1) | (1) | (0) | – | (0) | – | – | – | – |
| Net income | (2) | (2) | (1) | (0) | (0) | (0) | (0) | (0) | (0) | (0) |
| Net income to common shareholders | (2) | (1) | (1) | (0) | – | – | – | – | – | – |